A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of UCB4940 in Patients With Psoriasis

Clinical trial NCT02529956 · COMPLETED

Trial details

NCT number: NCT02529956
Sponsor: UCB Celltech
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Mild to Moderate Psoriasis

Start date: 2012-11-01
Primary completion: 2014-01-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.